Non-coding RNAs and potential therapeutic targeting in cancer

S Toden, TJ Zumwalt, A Goel - … et Biophysica Acta (BBA)-Reviews on …, 2021 - Elsevier
Recent advances have begun to clarify the physiological and pathological roles of non-
coding RNAs (ncRNAs) in various diseases, including cancer. Among these, microRNAs …

MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer

L Zhang, Y Liao, L Tang - Journal of Experimental & Clinical Cancer …, 2019 - Springer
Abstract MicroRNA-34 (miR-34) has been reported to be dysregulated in various human
cancers and regarded as a tumor suppressive microRNA because of its synergistic effect …

Structure and function of cationic and ionizable lipids for nucleic acid delivery

D Sun, ZR Lu - Pharmaceutical Research, 2023 - Springer
Hereditary genetic diseases, cancer, and infectious diseases are affecting global health and
become major health issues, but the treatment development remains challenging. Gene …

Mir-34: a new weapon against cancer?

G Misso, MT Di Martino, G De Rosa, AA Farooqi… - … therapy-nucleic acids, 2014 - cell.com
The microRNA (miRNA)-34a is a key regulator of tumor suppression. It controls the
expression of a plethora of target proteins involved in cell cycle, differentiation and …

miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review

MT Di Martino, M Arbitrio, D Caracciolo… - … Therapy-Nucleic Acids, 2022 - cell.com
Among deregulated microRNAs (miRs) in human malignancies, miR-221 has been widely
investigated for its oncogenic role and as a promising biomarker. Moreover, recent evidence …

Targeting microRNAs in cancer gene therapy

W Ji, B Sun, C Su - Genes, 2017 - mdpi.com
MicroRNAs (miRNAs) are a kind of conserved small non-coding RNAs that participate in
regulating gene expression by targeting multiple molecules. Early studies have shown that …

MiR‐182‐3p targets TRF2 and impairs tumor growth of triple‐negative breast cancer

R Dinami, L Pompili, E Petti, M Porru… - EMBO Molecular …, 2023 - embopress.org
The telomeric repeat‐binding factor 2 (TRF2) is a telomere‐cap** protein that plays a key
role in the maintenance of telomere structure and function. It is highly expressed in different …

miRNAs and lncRNAs as novel therapeutic targets to improve cancer immunotherapy

MT Di Martino, C Riillo, F Scionti, K Grillone, N Polerà… - Cancers, 2021 - mdpi.com
Simple Summary Cancer onset and progression are promoted by high deregulation of the
immune system. Recently, major advances in molecular and clinical cancer immunology …

Lipid nanocarriers for microRNA delivery

M Scheideler, I Vidakovic, R Prassl - Chemistry and physics of lipids, 2020 - Elsevier
Non-coding RNAs (ncRNAs) like microRNAs (miRNAs) or small interference RNAs (siRNAs)
with their power to selectively silence any gene of interest enable the targeting of so far …

IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis

Y Zhou, T Huang, HL Siu, CC Wong, Y Dong, F Wu… - Molecular cancer, 2017 - Springer
Background Gastric cancer (GC) is one of the frequent causes of cancer-related death in
eastern Asian population. IGF2BP2 lists in the top rank up-regulated genes in GC, but its …